Teva Pharmaceutical Industries

This paper answers the questions proposed in the week 3 assignment list of Business 620, Strategic Management. It covers Teva Pharmaceutical’s competitive advantage in the generic pharmaceuticals industry, evaluates their resources, analyzes opportunities in innovative pharmaceuticals and biosimilars and how they should move forward in the near future. Teva is the leading producer of generic pharmaceuticals worldwide using mergers and acquisitions to consolidate the industry. This tactic allows for the lowest prices which has allowed them to stay atop the competition. In recent years, with stock prices falling, Teva has tried to branch out to biosimilars and innovative pharmaceuticals. Launching three major innovative drugs and purchasing companies to produce biosimilars has aided in business profits but the competition has taken note of the strategies used by Teva in the past and are now using them against them. Teva has a long road ahead if they plan to balance all three efforts and maintain market share in the generic pharmaceuticals field.